Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07196839 · ClinicalTrials.gov registry record
Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study
A clinical trial of Transthyretin (TTR) Amyloid Cardiomyopathy, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT07196839 is a study of Transthyretin (TTR) Amyloid Cardiomyopathy that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07196839, a study of Transthyretin (TTR) Amyloid Cardiomyopathy, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to determine the association of clinically prescribed, on-label, TTR stabilizing therapy (e.g. tafamidis or acoramidis) with levels of circulating transthyretin amyloid aggregates (TAAs, a surrogate for amyloid disease activity) measured serially over time in patients with transthyretin cardiac amyloidosis (ATTR-CA). To accomplish this objective, the hypothesis that TTR stabilizing therapy will be associated lower circulating TAAs over time will be tested. Completion of this study will advance the understanding of the influence of ATTR-CA treatments on circulating evidence of amyloidosis and justify the role of blood testing to monitor treatment response in patients with ATTR-CA.
Conditions Studied
Study Locations (1)
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-12-31 |
| Est. Completion | 2027-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07196839
The ClinicalTrials.gov registry entry for NCT07196839 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Transthyretin (TTR) Amyloid Cardiomyopathy appearing as the primary indexed condition, and to 0 interventions.
NCT07196839 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07196839 about?
NCT07196839 is a clinical study titled "Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study". The objective of this study is to determine the association of clinically prescribed, on-label, TTR stabilizing therapy (e.g. tafamidis or acoramidis) with levels of circulating transthyretin amyloid aggregates (TAAs, a surrogate for amyloid disease activity) measured serially over time in patients ...
What is the current status of trial NCT07196839?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-12-31. Estimated completion is 2027-03.
What conditions does trial NCT07196839 study?
This clinical trial studies the following conditions: Transthyretin (TTR) Amyloid Cardiomyopathy.
Who is sponsoring clinical trial NCT07196839?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07196839 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Transthyretin (TTR) Amyloid Cardiomyopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.